Phenylbutyrate attenuates the expression of Bcl-X(L), DNA-PK, caveolin-1, and VEGF in prostate cancer cells
about
Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells.Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A.The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cellsHistone deacetylase inhibitors in clinical development.The emerging role of the PI3-K-Akt pathway in prostate cancer progression.Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML.The role of histone deacetylases in prostate cancer.Finding the place of histone deacetylase inhibitors in prostate cancer therapy.Phenylbutyrate-a pan-HDAC inhibitor-suppresses proliferation of glioblastoma LN-229 cell line.Caveolin-1: a novel prognostic biomarker of radioresistance in cancer.The sensitivity to beta-carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells.Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line demonstrates a major influence on heat-shock proteins.Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin.Phenylbutyrate inhibits the invasive properties of prostate and breast cancer cell lines in the sea urchin embryo basement membrane invasion assay.
P2860
Q34145992-440C4D4F-EC15-4EC7-A6B7-794C3ACF747FQ34986770-4250B4D8-0E86-4C1E-A946-7C8915500A92Q35218534-E54310BC-0B55-4191-B2A1-5B15D03BE623Q35609717-82062491-84B3-4487-AB77-D9FB32BD8DBFQ36050987-433256BD-27D9-4E5E-BB5A-9A961B5D7E8EQ36379368-0149F481-7651-4F72-B3FD-308CC3982D4CQ37333510-BDF7B643-DD8F-4CB9-A5AB-A873B757DDCFQ37960198-8BD839E8-E8E0-4DE8-9191-2E588B4E4BA2Q38844777-1F76383F-5F29-4CFA-A4E7-23A281E0CEDEQ38953425-76F436F6-09AF-47A7-8FAE-0DB09E5CE7A5Q39960194-60A3E2D3-F43E-4540-9619-01A018756D64Q40621983-D63CFB0A-22BC-4FC0-AD9B-B7A2EAC12EA3Q43089139-61C56738-7EE5-4D6C-B912-84AE72BD47A7Q44128400-1DC45C14-ADE1-4C17-8C11-0500C104AA14
P2860
Phenylbutyrate attenuates the expression of Bcl-X(L), DNA-PK, caveolin-1, and VEGF in prostate cancer cells
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Phenylbutyrate attenuates the ...... VEGF in prostate cancer cells
@ast
Phenylbutyrate attenuates the ...... VEGF in prostate cancer cells
@en
Phenylbutyrate attenuates the ...... VEGF in prostate cancer cells
@nl
type
label
Phenylbutyrate attenuates the ...... VEGF in prostate cancer cells
@ast
Phenylbutyrate attenuates the ...... VEGF in prostate cancer cells
@en
Phenylbutyrate attenuates the ...... VEGF in prostate cancer cells
@nl
prefLabel
Phenylbutyrate attenuates the ...... VEGF in prostate cancer cells
@ast
Phenylbutyrate attenuates the ...... VEGF in prostate cancer cells
@en
Phenylbutyrate attenuates the ...... VEGF in prostate cancer cells
@nl
P2093
P2860
P356
P1433
P1476
Phenylbutyrate attenuates the ...... VEGF in prostate cancer cells
@en
P2093
P2860
P356
10.1038/SJ.NEO.7900165
P407
P577
2001-01-01T00:00:00Z